|
Jessica Piggee and Mike Spoganetz (Sr Alliance & Partnerships Leaders, A&P) run through highlights of ASCO 2021, citing research breakthroughs and innovations, and a noticeable emphasis on…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
Dr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
PI3K/AKT
pathway biomarkers analysis from the Phase III IPATential150 trial of ipatasertib plus abiraterone in metastatic
castration-resistant prostate cancer
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
CONTACT-03
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
CONTACT-02 VIDEO
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
CheckMate 9KD arm B final analysis
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
A phase 3 trial of capivasertib and abiraterone versus placebo and abiraterone in patients with de novo metastatic hormone-sensitive prostate cancer
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
HIF2a + cabozantinib phase II VIDEO
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
First result from the phase 3 Checkmate 274 trial of adjuvant nivolumab versus placebo in patients who underwent radical surgery for high risk muscle-invasive urothelial carcinoma
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
Cell cycle progression and PTEN VIDEO
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
KEYNOTE 365 cohort B
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
Checkmate 9ER VIDEO
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
HIF2a + lenvatinib vs cabozantinib Phase III VIDEO
Content Declaration
Keep for 3 Years
|
|
Overall Survival in patients with mCRPC who have PTEN tumor suppressor gene loss of function
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
Primary results of EV-301
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
JAVELIN 100 Bladder Japanese subgroup analysis
Content Declaration
Keep for 3 Years Language (In English)
English
|